{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:59:59Z","timestamp":1791010799449,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Comprehensive breast cancer risk prediction models enable identifying and targeting women at high-risk, while reducing interventions in those at low-risk. Breast cancer risk prediction models used in clinical practice have low discriminatory accuracy (0.53\u20130.64). Machine learning (ML) offers an alternative approach to standard prediction modeling that may address current limitations and improve accuracy of those tools. The purpose of this study was to compare the discriminatory accuracy of ML-based estimates against a pair of established methods\u2014the Breast Cancer Risk Assessment Tool (BCRAT) and Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We quantified and compared the performance of eight different ML methods to the performance of BCRAT and BOADICEA using eight simulated datasets and two retrospective samples: a random population-based sample of U.S. breast cancer patients and their cancer-free female relatives (<jats:italic>N<\/jats:italic>\u2009=\u20091143), and a clinical sample of Swiss breast cancer patients and cancer-free women seeking genetic evaluation and\/or testing (<jats:italic>N<\/jats:italic>\u2009=\u20092481).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Predictive accuracy (AU-ROC curve) reached 88.28% using ML-Adaptive Boosting and 88.89% using ML-random forest versus 62.40% with BCRAT for the U.S. population-based sample. Predictive accuracy reached 90.17% using ML-adaptive boosting and 89.32% using ML-Markov chain Monte Carlo generalized linear mixed model versus 59.31% with BOADICEA for the Swiss clinic-based sample.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>There was a striking improvement in the accuracy of classification of women with and without breast cancer achieved with ML algorithms compared to the state-of-the-art model-based approaches. High-accuracy prediction techniques are important in personalized medicine because they facilitate stratification of prevention strategies and individualized clinical management.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13058-019-1158-4","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T09:02:31Z","timestamp":1561021351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2817-3865","authenticated-orcid":false,"given":"Chang","family":"Ming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Viassolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Probst-Hensch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre O.","family":"Chappuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo D.","family":"Dinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Katapodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"issue":"10","key":"1158_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.7326\/0003-4819-151-10-200911170-00009","volume":"151","author":"HD Nelson","year":"2009","unstructured":"Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151(10):727\u201337 w237\u201342.","journal-title":"Ann Intern Med"},{"key":"1158_CR2","doi-asserted-by":"crossref","unstructured":"Arie S. Switzerland debates dismantling its breast cancer screening programme. BMJ. 2014;348. https:\/\/www.bmj.com\/content\/348\/bmj.g1625.ful.","DOI":"10.1136\/bmj.g1625"},{"key":"1158_CR3","unstructured":"Christine Bouchardy PP, Lorez M, Clough-Gorr K, Bordoni A, the NICER Working Group. Trends in Breast Cancer Survival in Switzerland. NICER. Zurich: Schweizer Krebsbulletin(Nr. 4\/2011); 2011."},{"issue":"11s","key":"1158_CR4","doi-asserted-by":"publisher","first-page":"S383","DOI":"10.1016\/j.jacr.2017.08.044","volume":"14","author":"MB Mainiero","year":"2017","unstructured":"Mainiero MB, Moy L, Baron P, Didwania AD, diFlorio RM, Green ED, et al. ACR Appropriateness Criteria((R)) breast cancer screening. J Am Coll Radiol. 2017;14(11s):S383\u2013s90.","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"1158_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10552-016-0835-1","volume":"28","author":"X Qin","year":"2017","unstructured":"Qin X, Tangka FK, Guy GP Jr, Howard DH. Mammography rates after the 2009 revision to the United States Preventive Services Task Force breast cancer screening recommendation. Cancer Causes Control. 2017;28(1):41\u20138.","journal-title":"Cancer Causes Control"},{"issue":"7","key":"1158_CR6","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1007\/s00330-016-4612-z","volume":"27","author":"F Sardanelli","year":"2017","unstructured":"Sardanelli F, Aase HS, Alvarez M, Azavedo E, Baarslag HJ, Balleyguier C, et al. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey. Eur Radiol. 2017;27(7):2737\u201343.","journal-title":"Eur Radiol"},{"issue":"11","key":"1158_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/jama.2014.12483","volume":"312","author":"MC King","year":"2014","unstructured":"King MC, Levy-Lahad E, Lahad A. Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award. Jama. 2014;312(11):1091\u20132.","journal-title":"Jama."},{"issue":"4","key":"1158_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s13058-014-0427-5","volume":"16","author":"HA Azim Jr","year":"2014","unstructured":"Azim HA Jr, Partridge AH. Biology of breast cancer in young women. Breast Cancer Res. 2014;16(4):427.","journal-title":"Breast Cancer Res."},{"issue":"7","key":"1158_CR9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1001\/jamaoncol.2015.2112","volume":"1","author":"SM Rosenberg","year":"2015","unstructured":"Rosenberg SM, Newman LA, Partridge AH. Breast cancer in young women: rare disease or public health problem? JAMA Oncol. 2015;1(7):877\u20138.","journal-title":"JAMA Oncol"},{"key":"1158_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejca.2017.11.002","volume":"90","author":"P Autier","year":"2018","unstructured":"Autier P, Boniol M. Mammography screening: a major issue in medicine. Eur J Cancer. 2018;90:34\u201362.","journal-title":"Eur J Cancer"},{"issue":"9","key":"1158_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.7326\/0003-4819-156-9-201205010-00002","volume":"156","author":"NT van Ravesteyn","year":"2012","unstructured":"van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, et al. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med. 2012;156(9):609\u201317.","journal-title":"Ann Intern Med"},{"issue":"5","key":"1158_CR12","doi-asserted-by":"publisher","first-page":"R92","DOI":"10.1186\/bcr3493","volume":"15","author":"SA Eccles","year":"2013","unstructured":"Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, et al. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res. 2013;15(5):R92.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"1158_CR13","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jamaoncol.2016.1025","volume":"2","author":"P Maas","year":"2016","unstructured":"Maas P, Barrdahl M, Joshi AD, Auer PL, Gaudet MM, Milne RL, et al. Breast cancer risk from modifiable and nonmodifiable risk factors among White women in the United States. JAMA Oncol. 2016;2(10):1295\u2013302.","journal-title":"JAMA Oncol."},{"issue":"10","key":"1158_CR14","doi-asserted-by":"publisher","first-page":"738","DOI":"10.7326\/0003-4819-151-10-200911170-00010","volume":"151","author":"JS Mandelblatt","year":"2009","unstructured":"Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151(10):738\u201347.","journal-title":"Ann Intern Med"},{"issue":"10","key":"1158_CR15","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/bjc.2011.118","volume":"104","author":"N Pashayan","year":"2011","unstructured":"Pashayan N, Duffy SW, Chowdhury S, Dent T, Burton H, Neal DE, et al. Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer. 2011;104(10):1656\u201363.","journal-title":"Br J Cancer"},{"issue":"1","key":"1158_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/0003-4819-155-1-201107050-00003","volume":"155","author":"JT Schousboe","year":"2011","unstructured":"Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011;155(1):10\u201320.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1158_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086858","volume":"9","author":"E Vilaprinyo","year":"2014","unstructured":"Vilaprinyo E, Forne C, Carles M, Sala M, Pla R, Castells X, et al. Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer. PLoS One. 2014;9(2):e86858.","journal-title":"PLoS One"},{"issue":"23","key":"1158_CR18","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1200\/JCO.2013.49.3122","volume":"31","author":"K Visvanathan","year":"2013","unstructured":"Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, et al. Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31(23):2942\u201362.","journal-title":"J Clin Oncol"},{"issue":"10","key":"1158_CR19","first-page":"698","volume":"159","author":"VA Moyer","year":"2013","unstructured":"Moyer VA. Medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;159(10):698\u2013708.","journal-title":"Ann Intern Med"},{"issue":"24","key":"1158_CR20","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","volume":"81","author":"MH Gail","year":"1989","unstructured":"Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879\u201386.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1158_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13058-018-0947-5","volume":"20","author":"X Wang","year":"2018","unstructured":"Wang X, Huang Y, Li L, Dai H, Song F, Chen K. Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis. Breast Cancer Res. 2018;20(1):18.","journal-title":"Breast Cancer Res"},{"issue":"8","key":"1158_CR22","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/sj.bjc.6604305","volume":"98","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer. 2008;98(8):1457\u201366.","journal-title":"Br J Cancer"},{"issue":"12","key":"1158_CR23","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/bjc.2015.409","volume":"113","author":"J Usher-Smith","year":"2015","unstructured":"Usher-Smith J, Emery J, Hamilton W, Griffin SJ, Walter FM. Risk prediction tools for cancer in primary care. Br J Cancer. 2015;113(12):1645\u201350.","journal-title":"Br J Cancer"},{"issue":"6","key":"1158_CR24","doi-asserted-by":"publisher","first-page":"e615","DOI":"10.3747\/co.23.2961","volume":"23","author":"JLE Gagnon","year":"2016","unstructured":"Gagnon JLE. The Clinical Advisory Committee on Breast Cancer Screening and Prevention, et al. Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies. Curr Oncol. 2016;23(6):e615\u201325.","journal-title":"Curr Oncol"},{"issue":"11","key":"1158_CR25","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/jmg.40.11.807","volume":"40","author":"E Amir","year":"2003","unstructured":"Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet. 2003;40(11):807\u201314.","journal-title":"J Med Genet"},{"issue":"1","key":"1158_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13058-015-0653-5","volume":"17","author":"AR Brentnall","year":"2015","unstructured":"Brentnall AR, Harkness EF, Astley SM, Donnelly LS, Stavrinos P, Sampson S, et al. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort. Breast Cancer Res. 2015;17(1):147.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"1158_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10549-011-1818-2","volume":"132","author":"C Meads","year":"2012","unstructured":"Meads C, Ahmed I, Riley RD. A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance. Breast Cancer Res Treat. 2012;132(2):365\u201377.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"1158_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.7326\/0003-4819-148-5-200803040-00004","volume":"148","author":"JA Tice","year":"2008","unstructured":"Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med. 2008;148(5):337\u201347.","journal-title":"Ann Intern Med"},{"issue":"13","key":"1158_CR29","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJMp1606181","volume":"375","author":"Z Obermeyer","year":"2016","unstructured":"Obermeyer Z, Emanuel EJ. Predicting the future - big data, machine learning, and clinical medicine. N Engl J Med. 2016;375(13):1216\u20139.","journal-title":"N Engl J Med"},{"issue":"5\u20136","key":"1158_CR30","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S1532-0464(03)00034-0","volume":"35","author":"S Dreiseitl","year":"2002","unstructured":"Dreiseitl S, Ohno-Machado L. Logistic regression and artificial neural network classification models: a methodology review. J Biomed Inform. 2002;35(5\u20136):352\u20139.","journal-title":"J Biomed Inform"},{"key":"1158_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1471-2288-12-102","volume":"12","author":"HC Chen","year":"2012","unstructured":"Chen HC, Kodell RL, Cheng KF, Chen JJ. Assessment of performance of survival prediction models for cancer prognosis. BMC Med Res Methodol. 2012;12:102.","journal-title":"BMC Med Res Methodol"},{"key":"1158_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005","volume":"13","author":"K Kourou","year":"2015","unstructured":"Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2015;13:8\u201317.","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"1158_CR33","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/cam4.1256","volume":"7","author":"RE Reinbolt","year":"2018","unstructured":"Reinbolt RE, Sonis S, Timmers CD, Fernandez-Martinez JL, Cernea A, de Andres-Galiana EJ, et al. Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithm. Cancer Med. 2018;7(1):240\u201353.","journal-title":"Cancer Med"},{"key":"1158_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-0381-4-12","volume":"4","author":"L Vanneschi","year":"2011","unstructured":"Vanneschi L, Farinaccio A, Mauri G, Antoniotti M, Provero P, Giacobini M. A comparison of machine learning techniques for survival prediction in breast cancer. BioData Min. 2011;4:12.","journal-title":"BioData Min"},{"issue":"3","key":"1158_CR35","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/aaa1ca","volume":"63","author":"M Heidari","year":"2018","unstructured":"Heidari M, Khuzani AZ, Hollingsworth AB, Danala G, Mirniaharikandehei S, Qiu Y, et al. Prediction of breast cancer risk using a machine learning approach embedded with a locality preserving projection algorithm. Phys Med Biol. 2018;63(3):035020.","journal-title":"Phys Med Biol"},{"key":"1158_CR36","volume-title":"Pedantics: functions to facilitate power and sensitivity analyses for genetic studies of natural populations","author":"M Morrissey","year":"2018","unstructured":"Morrissey M. Pedantics: functions to facilitate power and sensitivity analyses for genetic studies of natural populations; 2018."},{"key":"1158_CR37","volume-title":"MICE: multivariate imputation by chained equations","author":"S van Buuren","year":"2017","unstructured":"van Buuren S, Groothuis-Oudshoorn K, Robitzsch A, Vink G, Doove L, Jolani S, Schouten R, Gaffert P, Meinfelder F, Gray B. MICE: multivariate imputation by chained equations; 2017."},{"key":"1158_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-2407-13-97","volume":"13","author":"MC Katapodi","year":"2013","unstructured":"Katapodi MC, Northouse LL, Schafenacker AM, Duquette D, Duffy SA, Ronis DL, et al. Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening. BMC Cancer. 2013;13:97.","journal-title":"BMC Cancer"},{"issue":"3","key":"1158_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10552-017-0858-2","volume":"28","author":"MC Katapodi","year":"2017","unstructured":"Katapodi MC, Duquette D, Yang JJ, Mendelsohn-Victor K, Anderson B, Nikolaidis C, et al. Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study. Cancer Causes Control. 2017;28(3):191\u2013201.","journal-title":"Cancer Causes Control."},{"key":"1158_CR40","unstructured":"Progeny 9, Version March 2018. Family data and pedigree information was stored and manipulated using the genetic data management system (Progeny CLINICAL Version N) from Progeny Software (Progeny Software LLC, Delray Beach, FL www.progenygenetics.com)."},{"key":"1158_CR41","unstructured":"Team RC. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2017."},{"key":"1158_CR42","volume-title":"Breast cancer risk assessment. 2.0 ed","author":"F Zhang","year":"2018","unstructured":"Zhang F. Breast cancer risk assessment. 2.0 ed; 2018."},{"key":"1158_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-72347-1","volume-title":"Data Science and Predictive Analytics","author":"Ivo D. Dinov","year":"2018","unstructured":"Dinov ID. Data science and predictive analytics: biomedical and health applications using R. Cham: Springer; 2018."},{"issue":"13","key":"1158_CR44","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1001\/jama.2013.393","volume":"309","author":"TB Murdoch","year":"2013","unstructured":"Murdoch TB, Detsky AS. The inevitable application of big data to health care. JAMA. 2013;309(13):1351\u20132.","journal-title":"JAMA."},{"issue":"1","key":"1158_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40537-015-0016-1","volume":"2","author":"AW Toga","year":"2015","unstructured":"Toga AW, Dinov ID. Sharing big biomedical data. J Big Data. 2015;2(1):7.","journal-title":"J Big Data"},{"issue":"8","key":"1158_CR46","doi-asserted-by":"publisher","first-page":"e0157077","DOI":"10.1371\/journal.pone.0157077","volume":"11","author":"ID Dinov","year":"2016","unstructured":"Dinov ID, Heavner B, Tang M, Glusman G, Chard K, Darcy M, et al. Predictive big data analytics: a study of Parkinson\u2019s disease using large, complex, heterogeneous, incongruent, multi-source and incomplete observations. PLoS One. 2016;11(8):e0157077.","journal-title":"PLoS One"},{"key":"1158_CR47","volume-title":"unbalanced: racing for unbalanced methods selection","author":"AD Pozzolo","year":"2015","unstructured":"Pozzolo AD, Caelen O, Bontempi G. unbalanced: racing for unbalanced methods selection; 2015."},{"key":"1158_CR48","first-page":"321","volume":"16","author":"N Chawla","year":"2002","unstructured":"Chawla N, Bowyer K, Hall L, Kegelmeyer W. SMOTE: synthetic minority over-sampling technique. J Art Intell Res. 2002;16:321\u201357.","journal-title":"J Art Intell Res"},{"key":"1158_CR49","volume-title":"A study of cross-validation and bootstrap for accuracy estimation and model selection","year":"1995","unstructured":"Kohavi R, editor. A study of cross-validation and bootstrap for accuracy estimation and model selection. Montreal: International Joint Conference on Artificial Intelligence; 1995."},{"key":"1158_CR50","unstructured":"Ng AY. Preventing \u201cOverfitting\u201d of Cross-Validation Data. In: Proceedings of the Fourteenth International Conference on Machine Learning, vol. 657119. Burlington: Morgan Kaufmann Publishers Inc; 1997. p. 245\u201353."},{"key":"1158_CR51","volume-title":"Package \u2018crossval\u2019. Contains generic functions for performing cross validation and for computing diagnostic errors","author":"K Strimme","year":"2015","unstructured":"Strimme K. Package \u2018crossval\u2019. Contains generic functions for performing cross validation and for computing diagnostic errors; 2015."},{"issue":"1","key":"1158_CR52","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/jnu.12259","volume":"49","author":"KT Hickey","year":"2017","unstructured":"Hickey KT, Katapodi MC, Coleman B, Reuter-Rice K, Starkweather AR. Improving utilization of the family history in the electronic health record. J Nurs Scholarsh. 2017;49(1):80\u20136.","journal-title":"J Nurs Scholarsh"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-019-1158-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-019-1158-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-019-1158-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T06:05:42Z","timestamp":1650175542000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-019-1158-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,20]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1158"],"URL":"https:\/\/doi.org\/10.1186\/s13058-019-1158-4","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,20]]},"assertion":[{"value":"22 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is a secondary data analysis. Data used in this study was collected as part of a clinical trial or medical records. Institutional and\/or national research ethic committee has approved the data collection and management process.Informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"75"}}